We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Barr, Shire Settle Litigation Over Adderall

Law360 (November 1, 2003, 12:00 AM EST) -- Barr Laboratories Inc. and Shire Pharmaceuticals Group agreed to end litigation over attention deficit drug Adderall, the two companies said.

Shire sued Barr in 2002, charging that Barr's generic version of Shire's Adderall infringed on Shire's rights in the appearance of the product.

Adderall XR is a once daily extended-release, mixed salt amphetamine product that is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

In November 2002, Barr filed an ANDA for Adderall XR Capsules, 5 mg, 10 mg, 15 mg, 20 mg, 25...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.